AFWG Online Education Module 3: Optimizing Dosing in IFI Management
One of the main risk factors contributing to mortality of patients with invasive fungal infections (IFIs) is inadequate antifungal therapy. This could be from delayed treatment, inappropriate choice of antifungal agent, insufficient dose or poor attention to drug PK/PD. Individual patients require individualized, optimized therapy.
Delivered by Professor Deborah Marriott, this module examines the basics of echinocandin PK and PD, makes a case for echinocandin therapeutic drug monitoring (TDM), and discusses dosing recommendations for critically ill and obese patients.